Eriocitrin: A review of pharmacological effects - 10/09/22
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
Abstract |
The present study aimed to recognize the recent literature to highlight the pharmacological impacts and highlight the therapeutic potential of the active molecule eriocitrin. Citrus limon are a good resource of the flavanone eriocitrin (eriodictyol 7-O-β-D-rutinoside). Eriocitrin has potent biological actions due to its strong antioxidant, antitumor, anti-allergic, antidiabetic and anti-inflammatory activities. Eriocitrin is more potent in suppressing oxidative stress in diabetes mellitus (DM) and other chronic diseases incurred by excessive oxidative stress. During metabolism, eriocitrin is metabolized by gut microbiota, and a chain of molecules such as eriodictyol, methy-eriodictyol, 3,4-dihydroxyhydrocinnamic acid (DHCA), and much more conjugated molecules. More in-depth studies are recommended to explore this drug for clinical trials.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Eriocitrin is well distributed in the citrus family (lemon peels and juice). |
• | Great bioavailability mainly because of metabolic proficiency. |
• | Easy solubility in aqueous medium and at an optimum pH range. |
• | Huge pharmacological potential (immunity boost, anti-tumor, anti-obesity, anti-inflammatory, and antidiabetic properties). |
• | Lowers inflammations associated and aging associated diseases. |
Keywords : Eriocitrin, Citrus fruits, Eriodictyol, Microbiota, Oxidative stress, Metabolism
Plan
Vol 154
Article 113563- octobre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?